Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, CAMP4 Therapeutics Corp’s stock clocked out at $3.62, up 7.10% from its previous closing price of $3.38. In other words, the price has increased by $7.10 from its previous closing price. On the day, 58753.0 shares were traded. CAMP stock price reached its highest trading level at $3.71 during the session, while it also had its lowest trading level at $3.4.
Ratios:
To gain a deeper understanding of CAMP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.83 and its Current Ratio is at 9.83. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In the most recent recommendation for this company, Cantor Fitzgerald on October 02, 2025, initiated with a Overweight rating and assigned the stock a target price of $7.
On May 27, 2025, Wedbush started tracking the stock assigning a Outperform rating and target price of $8.Wedbush initiated its Outperform rating on May 27, 2025, with a $8 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 11 ’25 when 5AM Partners VI, LLC bought 2,941,176 shares for $1.53 per share. The transaction valued at 4,499,999 led to the insider holds 2,941,176 shares of the business.
Polaris Management Co. VII, L. bought 1,307,189 shares of CAMP for $1,999,999 on Sep 11 ’25. The 10% Owner now owns 2,825,500 shares after completing the transaction at $1.53 per share. On Sep 11 ’25, another insider, Nashat Amir, who serves as the Director of the company, bought 1,307,189 shares for $1.53 each. As a result, the insider paid 1,999,999 and bolstered with 2,825,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAMP now has a Market Capitalization of 169709712 and an Enterprise Value of 100800704. For the stock, the TTM Price-to-Sale (P/S) ratio is 44.66 while its Price-to-Book (P/B) ratio in mrq is 2.89. Its current Enterprise Value per Revenue stands at 26.513 whereas that against EBITDA is -1.952.
Stock Price History:
The Beta on a monthly basis for CAMP is 1.49, which has changed by -0.29436326 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, CAMP has reached a high of $10.80, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is 3.36%, while the 200-Day Moving Average is calculated to be 31.09%.
Shares Statistics:
It appears that CAMP traded 782.30K shares on average per day over the past three months and 82080 shares per day over the past ten days. A total of 46.88M shares are outstanding, with a floating share count of 18.23M. Insiders hold about 61.11% of the company’s shares, while institutions hold 34.39% stake in the company. Shares short for CAMP as of 1763078400 were 427457 with a Short Ratio of 0.55, compared to 1760486400 on 430220. Therefore, it implies a Short% of Shares Outstanding of 427457 and a Short% of Float of 1.3200001.
